Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:31 AM
Ignite Modification Date:
2025-12-25 @ 12:31 AM
NCT ID:
NCT05155267
Eligibility Criteria:
Inclusion Criteria for Chronic Kidney Disease (CKD) submitted to Hemodialysis:
* Participant submitted to hemodialysis for more than 3 months
* Between 18 and 85 years old
* Stable haemoglobin (more than 10 gr/dl)
* Absence of infectious disease at the date of sample collection and for a period of more than two weeks
* Absence of active neoplasia
* Stable vascular access
Inclusion Criteria for Chronic Kidney Disease (CKD) pre-dialysis:
* No hemodialysis treatment
* Between 18 and 85 years old
* Stable haemoglobin (more than 10 gr/dl)
* Glomerular filtration ≤ 20 ml/min
* Absence of infectious disease at the date of sample collection and for a period of more than two weeks
* Absence of active neoplasia
Inclusion Criteria for controls :
* Between 18 and 85 years old (paired by gender, age and lifestyle to the CKD patients)
* Absence of chronic kidney disease or dialysis treatment
* Absence of chronic pathology (including neoplasia)
* Absence of infectious disease at the date of sample collection and for a period of more than two weeks
* Spanish residence
Exclusion Criteria for both groups of CKD patients:
* Clinical instability
* Life expectancy of less than 12 months
* Coagulation system disorders
* Participation in other clinical study
* Pregnancy
* Unsigned informed consent
Exclusion criteria for controls:
* Participation in other clinical study
* Pregnancy
* Unsigned informed consent
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT05155267
Study Brief:
Protocol Section:
NCT05155267